Vir Biotechnology (VIR) Up on Positive Data From HDV Study - June 6, 2024 - Zacks.com

Retrieved on: 2024-06-06 17:32:06

Tags for this article:

Hepatitis D

Peginterferon-alfa

Interferon

Vir Biotechnology Inc.

Click the tags to see associated articles and topics

Vir Biotechnology (VIR) Up on Positive Data From HDV Study - June 6, 2024 - Zacks.com. View article details on hiswai:

Summary

The article discusses Vir Biotechnology's positive preliminary data on treatments for Hepatitis D, but it does not link directly to 'Neuroscience.' The provided tags relate to hepatitis treatments, and Vir Biotechnology Inc.'s research progress in related viruses.

Article found on: www.zacks.com

View Original Article